BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2018 9:38:46 AM | Browse: 952 | Download: 1419
Publication Name World Journal of Hepatology
Manuscript ID 37947
Country/Territory Zambia
Received
2018-04-26 01:26
Peer-Review Started
2018-04-26 08:26
To Make the First Decision
2018-05-09 00:24
Return for Revision
2018-05-09 01:56
Revised
2018-05-23 16:00
Second Decision
2018-07-06 09:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-07-10 05:05
Articles in Press
2018-07-10 05:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
2018-07-14 19:59
Typeset the Manuscript
2018-09-20 08:10
Publish the Manuscript Online
2018-09-27 09:38
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Authors 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Observational Study
Article Title Chronic hepatitis B virus monoinfection at a university hospital in Zambia
Manuscript Source Unsolicited Manuscript
All Author List Michael J Vinikoor, Edford Sinkala, Annie Kanunga, Mutinta Muchimba, Bright Nsokolo, Roma Chilengi, Gilles Wandeler, Joseph Mulenga, Tina Chisenga, Debika Bhattacharya, Michael S Saag, Graham Foster, Michael W Fried and Paul Kelly
ORCID
Author(s) ORCID Number
Michael J Vinikoor http://orcid.org/0000-0002-3862-7795
Edford Sinkala http://orcid.org/0000-0002-5678-4540
Annie Kanunga http://orcid.org/0000-0001-7636-591X
Mutinta Muchimba http://orcid.org/0000-0003-3163-712X
Bright Nsokolo http://orcid.org/0000-0002-9338-0350
Roma Chilengi http://orcid.org/0000-0003-0221-9527
Gilles Wandeler http://orcid.org/0000-0002-5278-8763
Joseph Mulenga http://orcid.org/0000-0003-2188-2586
Tina Chisenga http://orcid.org/0000-0001-5546-2825
Debika Bhattacharya http://orcid.org/0000-0002-2136-7763
Michael S Saag http://orcid.org/0000-0002-8866-1043
Graham Foster http://orcid.org/0000-0002-3704-386X
Michael W Fried http://orcid.org/0000-0003-2970-5410
Paul Kelly http://orcid.org/0000-0003-0844-6448
Funding Agency and Grant Number
Funding Agency Grant Number
School of Medicine at University of Alabama at Birmingham
Fogarty International Center K01TW009998
National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health U01AI069924
Swiss National Science Foundation (to Wandeler G) PZ0093_154730
Corresponding Author Michael J Vinikoor, MD, Assistant Professor, Department of Medicine, University of Alabama at Birmingham, BBRB 256, 845 19th Street South, Birmingham, AL 35294, United States. mjv3@uab.edu
Key Words Hepatitis B virus; Liver fibrosis; Treatment; Tenofovir; Africa
Core Tip Data to inform the scale-up of hepatitis B testing and treatment in Africa are badly lacking. Among 120 recently diagnosed hepatitis B surface antigen-positive and HIV negative adults in Zambia, Southern Africa, 10% met the WHO’s criteria for im­mediate antiviral therapy and an additional 40% had an “indeterminate” hepatitis B virus (HBV) phenotype with either elevated alanine aminotransferase or HBV DNA > 2000 IU/ml. Among 40 additional pati­ents who were antiviral therapy-experienced (primarily with tenofovir), tolerability and adherence were good; however, nearly half had incomplete HBV DNA sup­pression. Effective approaches to retain antiviral-ineli­gible HBV patients in care will be important in Zambia.
Publish Date 2018-09-27 09:38
Citation Vinikoor MJ, Sinkala E, Kanunga A, Muchimba M, Nsokolo B, Chilengi R, Wandeler G, Mulenga J, Chisenga T, Bhattacharya D, Saag MS, Foster G, Fried MW, Kelly P. Chronic hepatitis B virus monoinfection at a university hospital in Zambia. World J Hepatol 2018; 10(9): 622-628
URL http://www.wjgnet.com/1948-5182/full/v10/i9/622.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i9.622
Full Article (PDF) WJH-10-622.pdf
Full Article (Word) WJH-10-622.doc
STROBE Statement 37947-STROBE statement.pdf
Manuscript File 37947-Review.docx
Answering Reviewers 37947-Answering reviewers.pdf
Audio Core Tip 37947-Audio core tip.wav
Biostatistics Review Certificate 37947-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 37947-Conflict-of-interest statement.pdf
Copyright License Agreement 37947-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 37947-Grant application form(s).PDF
Signed Informed Consent Form(s) or Document(s) 37947-Signed-Informed-Consent-Form(s)-or-Document(s)-revision.pdf
Institutional Review Board Approval Form or Document 37947-Institutional review board statement.pdf
Peer-review Report 37947-Peer-review(s).pdf
Scientific Misconduct Check 37947-Scientific misconduct check.pdf
Scientific Editor Work List 37947-Scientific editor work list.pdf